Clinical efficacy study of clopidogrel combined with fluvastatin in the treatment of cerebral infarction
Jiaji Liu
Armed Police Hainan Corps Hospital,Meilan District,Haikou,Hainan, 570200
Abstract:Objective:Exploring the clinical efficacy of clopidogrel combined with fluvastatin in the treatment of patients with cerebral infarction. Method: Sixty patients admitted to Jianhua Hospital in Qiqihar,Heilongjiang Province from November 2024 to November 2025 were selected as the target of this study,mainly patients with cerebral infarction. According to the random method,all patients were divided into a reference group(30 patients)and a study group(30 patients);The reference group received conventional treatment combined with clopidogrel monotherapy;The research group implemented fluatorvastatin treatment on the basis of the reference group;Afterwards,the treatment efficacy,NIHSS score,ADL score,blood lipid indicators,and incidence of adverse reactions were compared between the two groups of patients.Result:The above indicators in the observation group were better than those in the control group(P<0.05);There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion:The combination of clopidogrel and fluvastatin has shown significant therapeutic effects in the treatment of cerebral infarction,effectively optimizing patients' neurological function and daily living ability,while also playing a good regulatory role in lipid metabolism. Its safety has been fully verified,therefore it has the value of being widely promoted and applied in clinical practice.
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.